BACKGROUND: Adolescents consume more sugar-sweetened beverages than do individuals in any other age group, but it is unknown how the type of sugar-sweetened beverage affects metabolic health in this population. OBJECTIVE: The objective was to compare the metabolic health effects of short-term (2-wk) consumption of high-fructose (HF) and high-glucose (HG)-sweetened beverages in adolescents (15-20 y of age). DESIGN: In a counterbalanced, single-blind fashion, 40 male and female adolescents completed two 2-wk trials that included 1) an HF trial in which they consumed 710 mL of a sugar-sweetened beverage/d (equivalent to 50 g fructose/d and 15 g glucose/d) for 2 wk and 2) an HG trial in which they consumed 710 mL of a sugar-sweetened beverage/d (equivalent to 50 g glucose/d and 15 g fructose/d) for 2 wk in addition to their normal ad libitum diet. In addition, the participants maintained similar physical activity levels during each trial. The day after each trial, insulin sensitivity and resistance [assessed via Quantitative Insulin Sensitivity Check Index (QUICKI) and homeostatic model assessment of insulin resistance (HOMA-IR) index] and fasting and postprandial glucose, lactate, lipid, cholesterol, insulin, C-peptide, insulin secretion, and clearance responses to HF or HG mixed meals were assessed. RESULTS:Body weight, QUICKI (whole-body insulin sensitivity), HOMA-IR (hepatic insulin resistance), and fasting lipids, cholesterol, glucose, lactate, and insulin secretion or clearance were not different between trials. Fasting HDL- and HDL₃-cholesterol concentrations were ∼10-31% greater (P < 0.05) in female adolescents than in male adolescents. Postprandial triacylglycerol, HDL-cholesterol, HDL₃-cholesterol, and glucose concentrations were not different between HF and HG trials. The lactate incremental area under the curve was ∼3.7-fold greater during the HF trial (P < 0.05), whereas insulin secretion was 19% greater during the HG trial (P < 0.05). CONCLUSIONS: Moderate amounts of HF- or HG-sweetened beverages for 2 wk did not have differential effects on fasting or postprandial cholesterol, triacylglycerol, glucose, or hepatic insulin clearance in weight-stable, physically active adolescents.
RCT Entities:
BACKGROUND: Adolescents consume more sugar-sweetened beverages than do individuals in any other age group, but it is unknown how the type of sugar-sweetened beverage affects metabolic health in this population. OBJECTIVE: The objective was to compare the metabolic health effects of short-term (2-wk) consumption of high-fructose (HF) and high-glucose (HG)-sweetened beverages in adolescents (15-20 y of age). DESIGN: In a counterbalanced, single-blind fashion, 40 male and female adolescents completed two 2-wk trials that included 1) an HF trial in which they consumed 710 mL of a sugar-sweetened beverage/d (equivalent to 50 g fructose/d and 15 g glucose/d) for 2 wk and 2) an HG trial in which they consumed 710 mL of a sugar-sweetened beverage/d (equivalent to 50 g glucose/d and 15 g fructose/d) for 2 wk in addition to their normal ad libitum diet. In addition, the participants maintained similar physical activity levels during each trial. The day after each trial, insulin sensitivity and resistance [assessed via Quantitative Insulin Sensitivity Check Index (QUICKI) and homeostatic model assessment of insulin resistance (HOMA-IR) index] and fasting and postprandial glucose, lactate, lipid, cholesterol, insulin, C-peptide, insulin secretion, and clearance responses to HF or HG mixed meals were assessed. RESULTS: Body weight, QUICKI (whole-body insulin sensitivity), HOMA-IR (hepatic insulin resistance), and fasting lipids, cholesterol, glucose, lactate, and insulin secretion or clearance were not different between trials. Fasting HDL- and HDL₃-cholesterol concentrations were ∼10-31% greater (P < 0.05) in female adolescents than in male adolescents. Postprandial triacylglycerol, HDL-cholesterol, HDL₃-cholesterol, and glucose concentrations were not different between HF and HG trials. The lactate incremental area under the curve was ∼3.7-fold greater during the HF trial (P < 0.05), whereas insulin secretion was 19% greater during the HG trial (P < 0.05). CONCLUSIONS: Moderate amounts of HF- or HG-sweetened beverages for 2 wk did not have differential effects on fasting or postprandial cholesterol, triacylglycerol, glucose, or hepatic insulin clearance in weight-stable, physically active adolescents.
Authors: Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Isabelle Aeberli; Philipp A Gerber; Michel Hochuli; Sibylle Kohler; Sarah R Haile; Ioanna Gouni-Berthold; Heiner K Berthold; Giatgen A Spinas; Kaspar Berneis Journal: Am J Clin Nutr Date: 2011-06-15 Impact factor: 7.045
Authors: Ran Jin; Ngoc-Anh Le; Shuling Liu; Monica Farkas Epperson; Thomas R Ziegler; Jean A Welsh; Dean P Jones; Craig J McClain; Miriam B Vos Journal: J Clin Endocrinol Metab Date: 2012-04-27 Impact factor: 5.958
Authors: R Neil A Black; Michelle Spence; Ross O McMahon; Geraldine J Cuskelly; Cieran N Ennis; David R McCance; Ian S Young; Patrick M Bell; Steven J Hunter Journal: Diabetes Date: 2006-12 Impact factor: 9.461
Authors: Margarita S Treuth; Agneta L Sunehag; Lynn M Trautwein; Dennis M Bier; Morey W Haymond; Nancy F Butte Journal: Am J Clin Nutr Date: 2003-02 Impact factor: 7.045
Authors: V Lecoultre; L Egli; G Carrel; F Theytaz; R Kreis; P Schneiter; A Boss; K Zwygart; K-A Lê; M Bortolotti; C Boesch; L Tappy Journal: Obesity (Silver Spring) Date: 2013-04 Impact factor: 5.002
Authors: Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel Journal: Nutr Metab (Lond) Date: 2012-07-24 Impact factor: 4.169
Authors: Richard D Johnston; Mary C Stephenson; Hannah Crossland; Sally M Cordon; Elisa Palcidi; Eleanor F Cox; Moira A Taylor; Guruprasad P Aithal; Ian A Macdonald Journal: Gastroenterology Date: 2013-07-19 Impact factor: 22.682
Authors: Nathan C Winn; Ryan Pettit-Mee; Lauren K Walsh; Robert M Restaino; Sean T Ready; Jaume Padilla; Jill A Kanaley Journal: Med Sci Sports Exerc Date: 2019-05 Impact factor: 5.411
Authors: Miriam B Vos; Jill L Kaar; Jean A Welsh; Linda V Van Horn; Daniel I Feig; Cheryl A M Anderson; Mahesh J Patel; Jessica Cruz Munos; Nancy F Krebs; Stavra A Xanthakos; Rachel K Johnson Journal: Circulation Date: 2016-08-22 Impact factor: 29.690
Authors: Laura Chiavaroli; Russell J de Souza; Vanessa Ha; Adrian I Cozma; Arash Mirrahimi; David D Wang; Matthew Yu; Amanda J Carleton; Marco Di Buono; Alexandra L Jenkins; Lawrence A Leiter; Thomas M S Wolever; Joseph Beyene; Cyril W C Kendall; David J A Jenkins; John L Sievenpiper Journal: J Am Heart Assoc Date: 2015-09-10 Impact factor: 5.501
Authors: Vivian L Choo; Effie Viguiliouk; Sonia Blanco Mejia; Adrian I Cozma; Tauseef A Khan; Vanessa Ha; Thomas M S Wolever; Lawrence A Leiter; Vladimir Vuksan; Cyril W C Kendall; Russell J de Souza; David J A Jenkins; John L Sievenpiper Journal: BMJ Date: 2018-11-21
Authors: Jarvis C Noronha; Catherine R Braunstein; Sonia Blanco Mejia; Tauseef A Khan; Cyril W C Kendall; Thomas M S Wolever; Lawrence A Leiter; John L Sievenpiper Journal: Nutrients Date: 2018-11-20 Impact factor: 5.717